BVF Inc’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,629,000
| Closed | -$21.2M | – | 81 |
|
|
2022
Q4 | $21.2M | Hold |
3,629,000
| – | – | 0.89% | 36 |
|
|
2022
Q3 | $24.3M | Hold |
3,629,000
| – | – | 1% | 33 |
|
|
2022
Q2 | $15.3M | Buy |
3,629,000
+1,376,000
| +61% | +$5.44M | 0.74% | 38 |
|
|
2022
Q1 | $7.59M | Hold |
2,253,000
| – | – | 0.3% | 62 |
|
|
2021
Q4 | $7.1M | Buy |
+2,253,000
| New | +$7.5M | 0.26% | 60 |
|
|
2019
Q3 | – | Sell |
-1,628,187
| Closed | -$19.5M | – | 61 |
|
|
2019
Q2 | $19.5M | Buy |
1,628,187
+242,700
| +18% | +$2.61M | 2.13% | 15 |
|
|
2019
Q1 | $16.7M | Buy |
1,385,487
+235,042
| +20% | +$3.46M | 1.87% | 19 |
|
|
2018
Q4 | $14.4M | Sell |
1,150,445
-441,693
| -28% | -$6.1M | 1.89% | 16 |
|
|
2018
Q3 | $23.6M | Sell |
1,592,138
-225,000
| -12% | -$3.54M | 2.08% | 19 |
|
|
2018
Q2 | $30.6M | Sell |
1,817,138
-114,985
| -6% | -$2.23M | 2.98% | 12 |
|
|
2018
Q1 | $44.2M | Sell |
1,932,123
-37,666
| -2% | -$838K | 4.49% | 8 |
|
|
2017
Q4 | $51M | Sell |
1,969,789
-1,165,500
| -37% | -$23.5M | 6.14% | 5 |
|
|
2017
Q3 | $46.2M | Buy |
3,135,289
+1,278,394
| +69% | +$18.6M | 5.88% | 5 |
|
|
2017
Q2 | $25.9M | Sell |
1,856,895
-479,714
| -21% | -$7.07M | 4.02% | 10 |
|
|
2017
Q1 | $39.9M | Sell |
2,336,609
-279,640
| -11% | -$3.35M | 6.78% | 5 |
|
|
2016
Q4 | $26.9M | Sell |
2,616,249
-106,961
| -4% | -$978K | 5.41% | 5 |
|
|
2016
Q3 | $27.5M | Sell |
2,723,210
-32,108
| -1% | -$351K | 5.19% | 8 |
|
|
2016
Q2 | $30.9M | Hold |
2,755,318
| – | – | 6.59% | 5 |
|
|
2016
Q1 | $37.6M | Buy |
2,755,318
+523,304
| +23% | +$7.53M | 9.31% | 2 |
|
|
2015
Q4 | $42.3M | Sell |
2,232,014
-23,154
| -1% | -$503K | 7.22% | 4 |
|
|
2015
Q3 | $42.3M | Sell |
2,255,168
-266,284
| -11% | -$4.53M | 8.55% | 5 |
|
|
2015
Q2 | $37.5M | Buy |
2,521,452
+1,180,793
| +88% | +$18M | 6.63% | 5 |
|
|
2015
Q1 | $20.3M | Buy |
1,340,659
+134,200
| +11% | +$1.87M | 4.25% | 9 |
|
|
2014
Q4 | $16.1M | Hold |
1,206,459
| – | – | 3.13% | 12 |
|
|
2014
Q3 | $15.2M | Buy |
+1,206,459
| New | +$11.7M | 3.16% | 11 |
|
BVF Inc's CNCE Position: Q1 2023 in Review
BVF Inc sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 3,629,000 shares — an estimated $21.2M sold.
BVF Inc first reported a position in CNCE in Q3 2014 and held it in 25 quarters. The position peaked at $51M in Q4 2017. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- BVF Inc reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- BVF Inc sold 3,629,000 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $21.2M.
- BVF Inc first reported a position in Concert Pharmaceuticals, Inc. in Q3 2014 and held it in 25 quarters.
- BVF Inc's Concert Pharmaceuticals, Inc. position peaked at $51M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on BVF Inc's 13F filing for Q1 2023, filed 15 May 2023.